Veerhealth Care Ltd.
BSE: 511523 | Sector: Health care |
NSE: NIYATILEAS | ISIN Code: INE882C01035 |
BSE 00:00 | 16 May | 12.25 |
0 (0.00%) |
OPEN
12.25 |
HIGH
12.25 |
LOW
12.25 |
NSE 05:30 | 01 Jan | Veerhealth Care Ltd |
OPEN | 12.25 |
PREVIOUS CLOSE | 12.25 |
VOLUME | 600 |
52-Week high | 18.98 |
52-Week low | 8.20 |
P/E | 175.00 |
Mkt Cap.(Rs cr) | 8 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Veerhealth Care Ltd. (NIYATILEAS) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 885.75 | 0.41 | 966.90 | 652.75 | 212517.99 |
Divi's Lab. | 4219.55 | -1.50 | 5425.00 | 3790.00 | 112007.96 |
Cipla | 933.10 | 0.03 | 1083.15 | 850.00 | 75282.51 |
Dr Reddy's Labs | 3887.25 | -0.92 | 5613.65 | 3655.00 | 64691.61 |
Apollo Hospitals | 3688.20 | 3.95 | 5930.70 | 3099.15 | 53028.94 |
Gland Pharma | 3109.65 | 3.81 | 4350.00 | 2751.00 | 51184.84 |
Piramal Enterp. | 1875.00 | 3.39 | 3013.00 | 1616.10 | 44746.87 |
Torrent Pharma. | 2584.45 | 0.12 | 3304.45 | 2485.00 | 43734.06 |
Biocon | 319.90 | -2.01 | 420.25 | 314.90 | 38407.19 |
Max Healthcare | 367.95 | 0.97 | 472.60 | 205.00 | 35677.54 |
Zydus Lifesci. | 345.15 | 1.31 | 668.85 | 319.40 | 35333.01 |
Abbott India | 16529.20 | -0.08 | 23902.30 | 15525.00 | 35124.55 |
Alkem Lab | 2901.90 | -0.04 | 4067.70 | 2835.00 | 34692.21 |
Aurobindo Pharma | 550.75 | -2.03 | 1043.00 | 545.75 | 32268.44 |
Lupin | 684.65 | -1.67 | 1267.50 | 672.80 | 31117.34 |
Laurus Labs | 542.30 | 0.72 | 723.55 | 433.20 | 29140.49 |
Glaxosmi. Pharma | 1514.10 | 1.51 | 1917.00 | 1433.05 | 25650.37 |
Ipca Labs. | 983.90 | 0.92 | 1383.55 | 917.00 | 24961.54 |
Syngene Intl. | 533.55 | 1.07 | 699.95 | 508.10 | 21418.30 |
Pfizer | 4207.75 | -1.06 | 6164.80 | 4077.80 | 19250.46 |
Quick Links for Veerhealth Care:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices